Pembrolizumab for primary malignant melanoma of the central nervous system
We thank Arnault de la Fouchardière, MD, PhD (Department of Biopathology, Centre Leon Berard, Lyon) for his work on the molecular analysis.
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
Research involving human and animals participants
This article does not contain any studies with human participants or animals performed by any of the authors.